News Daily News Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests Todd Neale January 09, 2019
News Conference News AHA 2018 Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF Todd Neale November 11, 2018
News Daily News DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus Caitlin E. Cox October 04, 2018
News Daily News Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms Todd Neale October 03, 2018
News Daily News Out-of-Hospital Cardiac Arrest Protocol With Cooling, Angiography Gets ‘Extraordinary’ Results Caitlin E. Cox September 19, 2018
News Daily News Good INR Control on Warfarin Doesn’t Necessarily Predict Future Success, Outcomes Todd Neale September 13, 2018
News Daily News Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows Michael O'Riordan September 12, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News Edoxaban Looks Good for Asians With A-fib in Real-world Analysis Todd Neale August 14, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Daily News Asian Patients With A-fib Don’t Gain Anything From Low-Dose Rivaroxaban Todd Neale July 24, 2018
News Daily News Real-world Analysis Suggests Apixaban Is Safest of the NOACs, Even for Patients With A-fib L.A. McKeown July 06, 2018
News Daily News ICD Use Curbed at Hospitals After US Department of Justice Scrutiny Caitlin E. Cox July 05, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Daily News Postoperative A-fib Not as Bad as Nonsurgical A-fib for Thromboembolism Todd Neale March 29, 2018
News Conference News ACC 2018 Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4 Todd Neale March 13, 2018